Cargando…
2606. Epidemiology of invasive pneumococcal disease in adults with and without underlying lung disease in Ontario, Canada
BACKGROUND: The advent of enhanced conjugate pneumococcal vaccines for adults has created a need to assess the burden of pneumococcal disease in different populations to support recommendations for vaccination. We assessed the epidemiology of invasive pneumococcal disease (IPD) in adults with underl...
Autores principales: | Zhong, Zoe, Shigayeva, Altynay, Plevneshi, Agron, Martin, Irene, Demczuk, Walter, Kus, Julianne, Baqi, Mahin, Chen, Danny, Gold, Wayne, Lovinsky, Reena, Rau, Neil, Richardson, David, McGeer, Allison |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678361/ http://dx.doi.org/10.1093/ofid/ofad500.2220 |
Ejemplares similares
-
1309. Incidence and Epidemiology of Invasive Pneumococcal Disease due to Serotype 3 in South-Central Ontario
por: McGeer, Allison, et al.
Publicado: (2021) -
295. Is Herd Immunity from Pneumococcal Conjugate Vaccines Changing the Clinical Features of Invasive Pneumococcal Disease in Adults?
por: McGeer, Allison, et al.
Publicado: (2020) -
1426. Impact of Routine Pediatric PCV13 on the Incidence and Severity of Invasive Pneumococcal Disease in Adults in Ontario, Canada
por: Nayani, Sarah, et al.
Publicado: (2018) -
2716. Persistence of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Serotypes in Invasive Pneumococcal Disease in Adults in Southern Ontario Canada Despite Routine Pediatric Vaccination
por: McGeer, Allison, et al.
Publicado: (2019) -
2401. Risk Factors for Antimicrobial Resistance in Invasive Pneumococcal disease (IPD) in Toronto, Canada, 2012–2017
por: Fear, Thomas, et al.
Publicado: (2018)